Holen Sie sich die Stockscreener-App
17.50
7.89%
-1.50
Vorhandelsmarkt:
17.19
-0.31
-1.77%
Schlusskurs vom Vortag:
$19.00
Offen:
$19.04
24-Stunden-Volumen:
71,263
Relative Volume:
1.10
Marktkapitalisierung:
$32.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-10.07%
1M Leistung:
+25.72%
6M Leistung:
+257.14%
1J Leistung:
+0.00%
1-Tages-Spanne:
$17.07
$19.21
1-Wochen-Bereich:
$17.07
$21.40
52-Wochen-Spanne:
$2.90
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Firmenname
Neuphoria Therapeutics Inc
Sektor
Branche
Telefon
781-439-5551
Adresse
100 SUMMIT DR, BURLINGTON
Vergleichen Sie NEUP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
17.50 | 44.79M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-28 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Bestätigt | Maxim Group | Buy |
| 2022-01-10 | Eingeleitet | Berenberg | Buy |
| 2022-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Eingeleitet | Evercore ISI | Outperform |
| 2022-01-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten
Is Neuphoria Therapeutics Inc. stock cheap compared to fundamentals2025 Year in Review & Reliable Entry Point Trade Alerts - newser.com
Ranking Neuphoria Therapeutics Inc. among high performing stocks via toolsWeekly Trade Summary & Verified Momentum Watchlists - newser.com
Can Neuphoria Therapeutics Inc. stock weather global recessionJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Neuphoria Therapeutics Inc. stock outlook for YEARJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com
Should you wait for a breakout in Neuphoria Therapeutics Inc.2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
Comparing Neuphoria Therapeutics Inc. in custom built stock radarsJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
Will Neuphoria Therapeutics Inc. stock gain from government policies2025 Trading Volume Trends & Real-Time Volume Surge Alerts - newser.com
What machine learning models say about Neuphoria Therapeutics Inc.Quarterly Profit Summary & Verified Momentum Stock Alerts - newser.com
Measuring Neuphoria Therapeutics Inc.’s beta against major indicesJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
Will Neuphoria Therapeutics Inc. stock maintain momentum in 2025Trade Performance Summary & AI Enhanced Trading Alerts - newser.com
Neuphoria Therapeutics Inc. stock volume spike explainedTrade Risk Report & Free High Return Stock Watch Alerts - newser.com
What candlestick patterns are forming on Neuphoria Therapeutics Inc.July 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com
Can volume confirm reversal in Neuphoria Therapeutics Inc.July 2025 Retail & Free Reliable Trade Execution Plans - newser.com
Published on: 2025-10-03 04:28:40 - newser.com
Published on: 2025-10-03 03:24:42 - newser.com
Published on: 2025-10-03 00:10:19 - newser.com
Reversal indicators forming on Neuphoria Therapeutics Inc. stockJuly 2025 Technicals & Fast Moving Stock Watchlists - newser.com
What drives Neuphoria Therapeutics Inc stock priceFibonacci Retracement Levels & Low Entry Investment Growth - earlytimes.in
Is Neuphoria Therapeutics Inc a good long term investmentPrice Momentum Alerts & Identify Breakout Stocks - earlytimes.in
Neuphoria completes patient visits in phase 3 social anxiety trial By Investing.com - Investing.com Nigeria
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates - GlobeNewswire
Neuphoria completes patient visits in phase 3 social anxiety trial - Investing.com India
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates - GlobeNewswire Inc.
Neuphoria Therapeutics Inc. SEC 10-K Report - TradingView
Finanzdaten der Neuphoria Therapeutics Inc-Aktie (NEUP)
Es liegen keine Finanzdaten für Neuphoria Therapeutics Inc (NEUP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):